News
India's stock benchmarks erased intraday losses to settle flat on Thursday, as news of a U.S.-Russia presidential meeting ...
India is a major supplier of prescription drugs, over-the-counter medications, and pharmaceutical ingredients to the United ...
These three stocks are back on the radar as defence orders pick up. With multi-year order books and strong growth visibility, they’re poised to benefit—though valuations leave little room for error.
The National Stock Exchange CEO, Ashish Chauhan, has recently shared the details about the timeline of NSE IPO launch. Here ...
The fund is based on the Nifty500 Flexicap Quality 30 Index, developed in partnership with NSE. The index combines quality ...
India's equity benchmarks rose on Monday, led by gains in metals and IT stocks, as hopes of a U.S. rate cut outweighed ...
An ETF that tracks stocks in India is struggling to rebound from its recent losing streak, after President Trump imposed 25% ...
President Trump’s latest tariff hike hits a U.S. trading partner that ranks in the top 10, but barely. India, which now faces a 50% levy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results